<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05058716</url>
  </required_header>
  <id_info>
    <org_study_id>19423</org_study_id>
    <nct_id>NCT05058716</nct_id>
  </id_info>
  <brief_title>Assessment of Clinical Effects of Coenzyme Q10 Levels in COVID-19 Patients in Intensive Care Unit</brief_title>
  <official_title>Our Study Will be Carried Out in Hacettepe University Anesthesiology and Reanimation Intensive Care Unit. COVID-19 Positive or Suspected Patients Will be Admitted to the Unit. Coenzyme Q10 Levels Will be Checked in the First Day of Hospitalization and Once a Week. The Relationship Between Results and Clinical Course Will be Evaluated.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hacettepe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hacettepe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will be done in Hacettepe University Anesthesiology and Reanimation Intensive Care&#xD;
      Unit. The investigators will accept COVID-19 diagnosed or suspected patients to the ICU. In&#xD;
      the first day of hospitalization and after that once a week, the investigators will take&#xD;
      blood samples from the patients to evaluate Coenzyme q10 levels. Our hypothesis is that there&#xD;
      is a relationship between low coenzyme q10 levels and poor clinical outcome.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>from the first day of hospitalization until the date of death from any cause</time_frame>
    <description>yes or no</description>
  </primary_outcome>
  <primary_outcome>
    <measure>duration of mechanical ventilation</measure>
    <time_frame>from the first day of hospitalization and during ICU stay period</time_frame>
    <description>days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>duration of vasopressor agent requirement</measure>
    <time_frame>from the first day of hospitalization and during ICU stay period</time_frame>
    <description>days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>any organ failure</measure>
    <time_frame>from the first day of hospitalization until the date of death from any cause or discharge from ICU</time_frame>
    <description>yes or no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>new thromboembolic event</measure>
    <time_frame>from the first day of hospitalization until the date of death from any cause or discharge from ICU</time_frame>
    <description>yes or no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU stay period</measure>
    <time_frame>from the first day of hospitalization until the date of death from any cause or discharge from ICU</time_frame>
    <description>days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital stay period</measure>
    <time_frame>from the first day of discharge from ICU to ward until the date of death or discharge from the hospital</time_frame>
    <description>days</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>COVID-19 positive patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>COVID-19 negative patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <description>weekly blood sample - coenzym q10 levels</description>
    <arm_group_label>COVID-19 negative patients</arm_group_label>
    <arm_group_label>COVID-19 positive patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hacettepe University Anesthesiology and Reanimation Intensive Care Unit&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  being under the age of 18&#xD;
&#xD;
          -  being pregnant&#xD;
&#xD;
          -  patient refusal&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hacettepe University Hospital</name>
      <address>
        <city>Ankara</city>
        <state>Altındağ</state>
        <zip>06230</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Merve Göknur Soysal Kaya, Research assisstant</last_name>
      <phone>0905345533181</phone>
      <email>soysal_mervegoknur@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Seda Banu Akıncı, Professor</last_name>
      <email>sedabanu@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 22, 2021</study_first_submitted>
  <study_first_submitted_qc>September 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hacettepe University</investigator_affiliation>
    <investigator_full_name>Merve Goknur Soysal Kaya</investigator_full_name>
    <investigator_title>Research assistant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

